Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ProThera Biologics
East Providence, Rhode Island, United Statesprotherabiologics.com ↗
- Ownership
- Private
- Employees
- ~20
- Development stage
- Other
01
Overview
ProThera has demonstrated the potential of IAIP therapy in numerous preclinical models and the use of IAIP as a biomarker in clinical samples. The company is developing both therapeutic products and diagnostic tools based on IAIP technology.
- Therapeutic areas
- GastroenterologyImmunologyCardiovascularInfectious Diseases
- Modalities
- Plasma-derived proteinsBiologics
- Industry
- Biotech
02
Partnerships
Takeda Pharmaceutical Company LimitedProMetic Life Sciences
Beyond the preview
Go deeper on ProThera Biologics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ProThera Biologics.